Subversion of cell signaling by pathogens

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 9, 2012, Pages

  Alto, Neal M ^a   Orth, Kim ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA;

BACTERIAL PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ONCOPROTEIN; UBIQUITIN; VIRUS PROTEIN;

BIOLOGICAL MODEL; CYTOSKELETON; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

BACTERIAL PROTEINS; CYTOSKELETON; GTP-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; LIPID METABOLISM; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, VIRAL; UBIQUITIN; VIRAL PROTEINS;

EID: 84866082963     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a006114     Document Type: Article

References (112)

1. Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, McMahon SA, Ghosh P, Hughes TR, Boone C, et al. 2006. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124: 133-145.
2. Andor A, Trulzsch K, Essler M, Roggenkamp A, Wiedemann A, Heesemann J, Aepfelbacher M. 2001. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol 3: 301-310.
3. Black DS, Bliska JB. 2000. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol 37: 515-527.
4. Broberg CA, Zhang L, Gonzalez H, Laskowski-Arce MA, Orth K. 2010. A Vibrio effector protein is an inositol phosphatase and disrupts host cell membrane integrity. Science 329: 1660-1662.
5. Broberg CA, Calder TJ, Orth K. 2011. Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect 13: 992-1001.
6. Brombacher E, Urwyler S, Ragaz C, Weber SS, Kami K, Overduin M, Hilbi H. 2009. Rab1 guanine nucleotide exchange factor SidM is a major phosphatidylinositol 4-phosphate-binding effector protein of Legionella pneumophila. J Biol Chem 284: 4846-4856.
7. Brown MS, Segal A, Stadtman ER. 1971. Modulation of glutamine synthetase adenylylation and deadenylylation is mediated by metabolic transformation of the P II -regulatory protein. Proc Natl Acad Sci 68: 2949-2953.
8. Buchwald G, Friebel A, Galan JE, Hardt WD, Wittinghofer A, Scheffzek K. 2002. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J 21: 3286-3295.
9. Campellone KG, Welch MD. 2010. A nucleator arms race: Cellular control of actin assembly. Nat Rev 11: 237-251.
10. Campellone KG, Robbins D, Leong JM. 2004. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nckindependent actin assembly. Dev Cell 7: 217-228.
11. Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM. 1989. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J 8: 1087-1092.
12. Charras G, Paluch E. 2008. Blebs lead the way: How to migrate without lamellipodia. Nat Rev 9: 730-736.
13. Cheng HC, Skehan BM, Campellone KG, Leong JM, Rosen MK. 2008. Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). Nature 454: 1009-1013.
14. ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Infect Immun 59: 4259-4262.
15. Coburn J, Wyatt RT, Iglewski BH, Gill DM. 1989. Several GTP-binding proteins, including p21c - H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S. J Biol Chem 264: 9004-9008.
16. Collier RJ. 2009. Membrane translocation by anthrax toxin. Mol Aspects Med 30: 413-422.
17. Collins CA, Brown EJ. 2010. Cytosol as battleground: Ubiquitin as a weapon for both host and pathogen. Trends Cell Biol 20: 205-213.
18. Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci 97: 8051-8056.
19. Cui J, Yao Q, Li S, Ding X, Lu Q, Mao H, Liu L, Zheng N, Chen S, Shao F. 2010. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329: 1215-1218.
20. Devreotes P, Horwitz A. 2012. Signal transduction and the regulation of cell migration. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005959.
21. Dobner T, Horikoshi N, Rubenwolf S, Shenk T. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473.
22. Egile C, Loisel TP, Laurent V, Li R, Pantaloni D, Sansonetti PJ, Carlier MF. 1999. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J Cell Biol 146: 1319-1332.
23. Engel P, Goepfert A, Stanger FV, Harms A, Schmidt A, Schirmer T, Dehio C. 2012. Adenylylation control by intraor intermolecular active-site obstruction in Fic proteins. Nature 482: 107-110.
24. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420: 629-635.
25. Everett RD. 2000. ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22: 761-770.
26. Finn RD, Mistry J, Tate J, Coggill P, Heger A, Pollington JE, Gavin OL, Gunasekaran P, Ceric G, Forslund K, et al. 2009. The Pfam protein families database. Nucleic Acids Res 38: D211-D222.
27. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387: 729-733.
28. Fu Y, Galan JE. 1999. A Salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401: 293-297.
29. Garcia-Pino A, Christensen-Dalsgaard M, Wyns L, Yarmolinsky M, Magnuson RD, Gerdes K, Loris R. 2008. Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J Biol Chem 283: 30821-30827.
30. Garmendia J, Phillips AD, Carlier MF, Chong Y, Schuller S, Marches O, Dahan S, Oswald E, Shaw RK, Knutton S, et al. 2004. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol 6: 1167-1183.
31. Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT. 1999. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem 274: 36369-36372.
32. Gruenheid S, DeVinney R, Bladt F, Goosney D, Gelkop S, Gish GD, Pawson T, Finlay BB. 2001. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat Cell Biol 3: 856-859.
33. Guan KL, Dixon JE. 1990. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249: 553-556.
34. Haas AL, Katzung DJ, Reback PM, Guarino LA. 1996. Functional characterization of the ubiquitin variant encoded by the baculovirus Autographa californica. Biochemistry 35: 5385-5394.
35. Ham H, Sreelatha A, Orth K. 2011. Manipulation of host membranes by bacterial effectors. Nat Rev Microbiol 9: 635-646.
36. Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K. 2008. Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways. PLoS ONE 3: e1375.
37. Haque M, Ueda K, Nakano K, Hirata Y, Parravicini C, Corbellino M, Yamanishi K. 2001. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J Gen Virol 82: 1175-1180.
38. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galan JE. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93: 815-826.
39. Hayes CS, Aoki SK, Low DA. 2010. Bacterial contact-dependent delivery systems. Annu Rev Genet 44: 71-90.
40. Henkel JS, Baldwin MR, Barbieri JT. 2010. Toxins from bacteria. EXS 100: 1-29.
41. Henriksson ML, Sundin C, Jansson AL, Forsberg A, Palmer RH, Hallberg B. 2002. Exoenzyme S shows selective ADP-ribosylation and GTPaseactivating protein (GAP) activities towards small GTPases in vivo. Biochem J 367: 617-628.
42. Hernandez LD, Hueffer K, Wenk MR, Galan JE. 2004. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 304: 1805-1807.
43. Holt MR, Koffer A. 2001. Cell motility: Proline-rich proteins promote protrusions. Trends Cell Biol 11: 38-46.
44. Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, Chai J, Alto NM. 2009. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol 16: 853-860.
45. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM. 1995. A family of proteins structurally and functionally related to the E6-AP ubiquitinprotein ligase. Proc Natl Acad Sci 92: 2563-2567.
46. Iriarte M, Cornelis GR. 1998. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol Microbiol 29: 915-929.
47. Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300-5309.
48. Jiang P, Mayo AE, Ninfa AJ. 2007. Escherichia coli glutamine synthetase adenylyltransferase (ATase, EC 2.7.7.49): Kinetic characterization of regulation by PII, PII-UMP, glutamine, and a-ketoglutarate. Biochemistry 46: 4133-4146.
49. Jubelin G, Taieb F, Duda DM, Hsu Y, Samba-Louaka A, Nobe R, Penary M, Watrin C, Nougayrede JP, Schulman BA, et al. 2010. Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog 6: e1001128.
50. Juris SJ, Rudolph AE, Huddler D, Orth K, Dixon JE. 2000. A distinctive role for the Yersinia protein kinase: Actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci 97: 9431-9436.
51. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-520.
52. Kinch LN, Yarbrough ML, Orth K, Grishin NV. 2009. Fido, a novel AMPylation domain common to fic, doc, and AvrB. PLoS ONE 4: e5818.
53. Klink BU, Barden S, Heidler TV, Borchers C, Ladwein M, Stradal TE, Rottner K, Heinz DW. 2010. Structure of Shigella IpgB2 in complex with human RhoA: Implications for the mechanism of bacterial guanine nucleotide exchange factor mimicry. J Biol Chem 285: 17197-17208.
54. Kubori T, Galan JE. 2003. Temporal regulation of Salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115: 333-342.
55. Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, Chen S, Zhou JM, Shao F. 2007. The phosphothreonine lyase activity of a bacterial type III effector family. Science 315: 1000-1003.
56. Liverman AD, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, Burdette DL, Rosen MK, Orth K. 2007. Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci 104: 17117-17122.
57. Luong P, Kinch LN, Brautigam CA, Grishin NV, Tomchick DR, Orth K. 2010. Kinetic and structural insights into the mechanism of AMPylation by VopS Fic domain. J Biol Chem 285: 20155-20163.
58. Miraglia AG, Travaglione S, Meschini S, Falzano L, Matarrese P, Quaranta MG, Viora M, Fiorentini C, Fabbri A. 2007. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IkB kinase pathway: Role of nuclear factor-κB and Bcl-2. Mol Biol Cell 18: 2735-2744.
59. Mittal R, Peak-Chew SY, McMahon HT. 2006. Acetylation of MEK2 and IkB kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci 103: 18574-18579.
60. Mohr C, Koch G, Just I, Aktories K. 1992. ADP-ribosylation by Clostridium botulinum C3 exoenzyme increases steady-state GTPase activities of recombinant rhoA and rhoB proteins. FEBS Lett 297: 95-99.
61. Morikawa H, Kim M, Mimuro H, Punginelli C, Koyama T, Nagai S, Miyawaki A, Iwai K, Sasakawa C. 2010. The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1. Biochem Biophys Res Commun 401: 268-274.
62. Morrison D. 2012. MAP kinase pathways. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a011254.
63. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K. 2006. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
64. Mukherjee S, Hao YH, Orth K. 2007. A newly discovered post-translational modification-The acetylation of serine and threonine residues. Trends Biochem Sci 32: 210-216.
65. Mukherjee S, Liu X, Arasaki K, McDonough J, Galan JE, Roy CR. 2011. Modulation of Rab GTPase function by a protein phosphocholine transferase. Nature 477: 103-106.
66. Mukhopadhyay D, Riezman H. 2007. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315: 201-205.
67. Muller MP, Peters H, Blumer J, Blankenfeldt W, Goody RS, Itzen A. 2010. The Legionella effector protein DrrA AMPylates the membrane traffic regulator Rab1b. Science 329: 946-949.
68. Murata T, Delprato A, Ingmundson A, Toomre DK, Lambright DG, Roy CR. 2006. The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor. Nat Cell Biol 8: 971-977.
69. Namgoong S, Boczkowska M, Glista MJ, Winkelman JD, Rebowski G, Kovar DR, Dominguez R. 2011. Mechanism of actin filament nucleation by Vibrio VopL and implications for tandem W domain nucleation. Nat Struct Mol Biol 18: 1060-1067.
70. Navarro L, Koller A, Nordfelth R, Wolf-Watz H, Taylor S, Dixon JE. 2007. Identification of a molecular target for the Yersinia protein kinase A. Mol Cell 26: 465-477.
71. Neunuebel MR, Chen Y, Gaspar AH, Backlund PSJr, Yergey A, Machner MP. 2011. De-AMPylation of the small GTPase Rab1 by the pathogen Legionella pneumophila. Science 333: 453-456.
72. Newton K, Dixit V. 2012. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a006049.
73. Niebuhr K, Jouihri N, Allaoui A, Gounon P, Sansonetti PJ, Parsot C. 2000. IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation. Mol Microbiol 38: 8-19.
74. Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B. 2002. Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J 21: 5069-5078.
75. Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW. 1998. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci 95: 14057-14059.
76. Offermanns S, Toombs CF, Hu YH, Simon MI. 1997. Defective platelet activation in Ga(q)-deficient mice. Nature 389: 183-186.
77. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE. 1999. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285: 1920-1923.
78. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE. 2000. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290: 1594-1597.
79. Pickart CM. 2004. Back to the future with ubiquitin. Cell 116: 181-190.
80. Prehna G, Ivanov MI, Bliska JB, Stebbins CE. 2006. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell 126: 869-880.
81. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW, Branton PE. 2001a. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 15: 3104-3117.
82. Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE. 2001b. Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6 - E1B55K complex. J Virol 75: 699-709.
83. Randow F, Lehner PJ. 2009. Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11: 527-534.
84. Rigden DJ. 2011. Identification and modelling of a PPM protein phosphatase fold in the Legionella pneumophila deAMPylase SidD. FEBS Lett 585: 2749-2754.
85. Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C. 2007. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1: 77-83.
86. Sallee NA, Rivera GM, Dueber JE, Vasilescu D, Mullins RD, Mayer BJ, Lim WA. 2008. The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency. Nature 454: 1005-1008.
87. Sassone-Corsi P. 2012. The cyclic AMP pathway. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a011148.
88. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV- 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
89. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387: 725-729.
90. Sehr P, Joseph G, Genth H, Just I, Pick E, Aktories K. 1998. Glucosylation and ADP ribosylation of rho proteins: Effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37: 5296-5304.
91. Selyunin AS, Sutton SE, Weigele BA, Reddick LE, Orchard RC, Bresson SM, Tomchick DR, Alto NM. 2011. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 469: 107-111.
92. Shao F, Merritt PM, Bao Z, Innes RW, Dixon JE. 2002. AYersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109: 575-588.
93. Shao F, Vacratsis PO, Bao Z, Bowers KE, Fierke CA, Dixon JE. 2003. Biochemical characterization of the Yersinia YopT protease: Cleavage site and recognition elements in Rho GTPases. Proc Natl Acad Sci 100: 904-909.
94. Singer AU, Rohde JR, Lam R, Skarina T, Kagan O, Dileo R, Chirgadze NY, Cuff ME, Joachimiak A, Tyers M, et al. 2008. Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases. Nat Struct Mol Biol 15: 1293-1301.
95. Staudt LM. 2012. TLR/NF-κB pathway. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a011247.
96. Stebbins CE, Galan JE. 2000. Modulation of host signaling by a bacterial mimic: Structure of the Salmonella effector SptP bound to Rac1. Mol Cell 6: 1449-1460.
97. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ. 2000. Inhibition of MHC class I-restricted antigen presentation by g2-herpesviruses. Proc Natl Acad Sci 97: 8455-8460.
98. Takai Y, Sasaki T, Matozaki T. 2001. Small GTP-binding proteins. Physiol Rev 81: 153-208.
99. Tan Y, Luo ZQ. 2011. Legionella pneumophila SidD is a deAMPylase that modifies Rab1. Nature 475: 506-509.
100. Terebiznik MR, Vieira OV, Marcus SL, Slade A, Yip CM, Trimble WS, Meyer T, Finlay BB, Grinstein S. 2002. Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol 4: 766-773.
101. Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K. 2004. Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem 279: 51953-51957.
102. Trosky JE, Li Y, Mukherjee S, Keitany G, Ball H, Orth K. 2007. VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J Biol Chem 282: 34299-34305.
103. Upadhyay A, Wu HL, Williams C, Field T, Galyov EE, van den Elsen JM, Bagby S. 2008. The guanine-nucleotide-exchange factor BopE from Burkholderia pseudomallei adopts a compact version of the Salmonella SopE/SopE2 fold and undergoes a closed-to-open conformational change upon interaction with Cdc42. Biochem J 411: 485-493.
104. Von Pawel-Rammingen U, Telepnev MV, Schmidt G, Aktories K, Wolf-Watz H, Rosqvist R. 2000. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: A mechanism for disruption of actin microfilament structure. Mol Microbiol 36: 737-748.
105. Welch MD, Rosenblatt J, Skoble J, Portnoy DA, Mitchison TJ. 1998. Interaction of human Arp2/3 complex and the Listeria monocytogenes ActA protein in actin filament nucleation. Science 281: 105-108.
106. Woolery AR, Luong P, Broberg CA, Orth K. 2010. AMPylation: Something old is new again. Front Microbiol 1: 113.
107. Worby CA, Mattoo S, Kruger RP, Corbeil LB, Koller A, Mendez JC, Zekarias B, Lazar C, Dixon JE. 2009. The Fic domain: Regulation of cell signaling by adenylylation. Mol Cell 34: 93-103.
108. Yaffe MB. 2012. Protein regulation. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005918.
109. Yarbrough ML, Li Y, Kinch LN, Grishin NV, Ball HL, Orth K. 2009. AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science 323: 269-272.
110. Yu Y, Wang SE, Hayward GS. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22: 59-70.
111. Yu B, Cheng HC, Brautigam CA, Tomchick DR, Rosen MK. 2011. Mechanism of actin filament nucleation by the bacterial effector VopL. Nat Struct Mol Biol 18: 1068-1074.
112. Zhu Y, Li H, Hu L, Wang J, Zhou Y, Pang Z, Liu L, Shao F. 2008. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol 15: 1302-1308.